$SARTORIUS STEDIM BIOTECH UNSPON ADS EACH REP 0.2 ORD SHS (SRTOY.US)$Will release financial report on October 17th, investors please pay attention.
How was the performance before?
$SARTORIUS STEDIM BIOTECH UNSPON ADS EACH REP 0.2 ORD SHS (SRTOY.US)$2024/Q2 revenue of 0.7064 billion euros, net income of 48.6 million euros, eps of 0.05 euros.
2023/Q2 revenue of 0.6757 billion euros, net income of 0.1331 billion euros, eps of 0.144 euros.
The accounting standards used in the above data are NonUS_GAAP.
Futubull Reminder:
1. The accounting year of Hong Kong stocks and U.S. listed companies is not rigidly defined, and is completely decided by the company itself, so each financial report period can be the deadline for the company's annual report, without using the natural year as the financial year.
2. Generally, the company will hold a financial report meeting on the above-mentioned financial report release date or near the date. The company's management will then discuss and explain the latest quarterly financial data and operational situation with investors, analysts, media, etc., and communicate through offline meetings or online conference calls, etc.
Investors can participate through offline meetings or online conference calls.